Moderna reports ‘positive’ data on early-stage coronavirus vaccine trial, shares surge 39% – CNBC

0
257
Moderna reports ‘positive’ data on early-stage coronavirus vaccine trial, shares surge 39% – CNBC

Moderna said its early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all participants, sending its shares surging.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here